20 Participants NeededMy employer runs this trial

Prehabilitation for Pancreatic Cancer

KR
JM
Overseen ByJames M Lindberg, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Massachusetts, Worcester
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a program called Multimodal Prehabilitation, designed to strengthen people with pancreatic cancer before surgery while they undergo chemotherapy. The program emphasizes physical fitness, nutrition, and symptom management to enhance recovery and overall experience. It aims to determine if patients can adhere to the program and if it speeds up post-surgery recovery. This trial suits adults with pancreatic cancer who plan to undergo chemotherapy and surgery and can safely exercise. As an unphased trial, it offers a unique opportunity for patients to improve their pre-surgery strength and recovery experience.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this prehabilitation program is safe for patients with pancreatic cancer?

Research has shown that prehabilitation programs, which involve various types of preparation before surgery, are generally safe for people with pancreatic cancer. In one study, participants experienced no negative effects during the program, indicating it is well-tolerated. Another study found that prehabilitation can help reduce serious complications after surgery, suggesting a positive impact on safety. Although surgery for pancreatic cancer can be challenging, the prehabilitation program appears to be a safe method to enhance recovery.12345

Why are researchers excited about this trial?

Researchers are excited about the Multimodal Prehabilitation Program for pancreatic cancer because it offers a proactive approach that combines exercise, nutrition, and psychological support before surgery. Unlike the standard treatment options, which primarily focus on chemotherapy and surgery, this program aims to boost patients' overall fitness and mental well-being during neoadjuvant chemotherapy. By enhancing patients' physical and mental resilience, this method could lead to better surgical outcomes and faster recovery times.

What evidence suggests that this prehabilitation program is effective for pancreatic cancer?

Research has shown that a program called multimodal prehabilitation can benefit people with pancreatic cancer. This program includes physical exercise, nutritional support, and psychological support. Studies have found that patients who participated in prehabilitation experienced fewer complications after surgery. For example, one study found that only 9.8% of patients who underwent prehabilitation had heart or lung problems, compared to those who did not. Another study demonstrated that patients recovered better around the time of surgery. This approach is safe and practical, improving physical function and recovery. Participants in this trial will receive a structured prehabilitation program during neoadjuvant chemotherapy before planned pancreatic cancer surgery.13467

Who Is on the Research Team?

JM

James M Lindberg, MD

Principal Investigator

UMass Memorial Health

Are You a Good Fit for This Trial?

This trial is for adults (18+) with pancreatic ductal adenocarcinoma who are medically stable, can exercise, and are scheduled to get chemotherapy before planned surgery. Participants must be able to understand English and provide consent. People who are pregnant or have serious heart or lung problems can't join.

Inclusion Criteria

I am 18 years old or older.
I have been diagnosed with pancreatic ductal adenocarcinoma.
I am scheduled to have chemotherapy before my surgery.
See 3 more

Exclusion Criteria

Pregnant
Contraindications to physical activity, including unstable cardiac disease, severe pulmonary disease, or recent myocardial infarction
I am younger than 18 years old.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Prehabilitation

Participants engage in a structured prehabilitation program during neoadjuvant chemotherapy to improve physical fitness, nutrition, and symptom control before surgery

3-6 months
Regular visits for assessments and program adherence checks

Surgery

Participants undergo planned pancreatic cancer surgery following the prehabilitation program

1 week
Hospital stay for surgery and immediate recovery

Follow-up

Participants are monitored for safety, effectiveness, and recovery after surgery

Up to 1 year
Postoperative assessments at 1 month and up to 1 year

What Are the Treatments Tested in This Trial?

Interventions

  • Multimodal Prehabilitation

Trial Overview

The study tests a structured prehabilitation program—focusing on fitness, nutrition, and symptom management—for people with pancreatic cancer during chemotherapy before surgery. It aims to see if patients can follow the program and if it helps recovery after surgery.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Multimodal Prehabilitation ProgramExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Massachusetts, Worcester

Lead Sponsor

Trials
372
Recruited
998,000+

Pancreatic Cancer Alliance

Collaborator

Citations

1.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/41618415/

Multimodal Prehabilitation In Pancreatic cancer Patients ...

Previous studies showed that preoperative low functional capacity and malnutrition have been associated with inferior postoperative outcomes.

Multimodal Prehabilitation In Pancreatic cancer Patients ...

Pancreatic cancer surgery is challenging and associated with up to a 70% complication rate, which translates to poor postoperative recovery ...

Personalized multimodal prehabilitation reduces ...

The authors concluded that prehabilitation was safe and feasible for patients with pancreatic cancer, with two reviewed studies also demonstrating a lower rate ...

Effect of a multimodal prehabilitation program on ...

After PSM, patient characteristics were well balanced. Significant less cardiopulmonary complications were observed in the prehabilitation cohort (9,8% versus ...

Prehabilitation in Pancreatic Surgery (NCT06069297)

The combination of surgical resection and chemotherapy represents the most efficacious therapy to improve prognosis for localized PDAC. Patients with pancreatic ...

Multimodal Prehabilitation In Pancreatic cancer Patients ...

Pancreatic cancer surgery is challenging and associated with up to a 70% complication rate, which translates to poor postoperative recovery and patient ...

NCT07389746 | Preoperative Physical Exercise, Nutritional ...

Multimodal Prehabilitation Reduces Postoperative Complications in High Risk Patients Undergoing Major Gastrointestinal Cancer Surgery. Conditions. Cancer ...